|
|
||||||||||||||
|
|
|||||||||||||||
II. Patients' and clinicians' preference |
K McPherson, professor of public health epidemiology1, A Britton, lecturer2
1 Department of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1 7HT, UK
2 Department of Epidemiology and Public Health, University College London, London WC1E 6BT, UK
Professor K McPherson k.mcpherson{at}lshtm.ac.uk Abstract
Preference for a particular intervention may, possibly via complicated pathways, itself confer an outcome advantage which will be subsumed in unblind randomised trials as part of the measured effectiveness of the intervention. Where more attractive interventions are compared with less attractive ones, any difference could therefore be a consequence of attractiveness and not its intrinsic worth. For health promotion interventions this is clearly important, but we cannot tell how important it is for therapeutic interventions without special studies to measure or refute such effects. These are difficult to do and are complex. Until the therapeutic effects of preference itself are more clearly understood, understanding the true therapeutic effects will be compromised, at least in principle.
Key Words: patient preference; randomised controlled trials; measurement
This article has been cited by other articles:
![]() |
F. Moss Doctors and their education: CPD in the modern and changing world Postgrad. Med. J., January 1, 2008; 84(987): 1 - 1. [Full Text] [PDF] |
||||
![]() |
A. Bowling and G. Rowe "You decide doctor". What do patient preference arms in clinical trials really mean? J Epidemiol Community Health, November 1, 2005; 59(11): 914 - 915. [Full Text] [PDF] |
||||
![]() |
G. DUNN, M. MARACY, C. DOWRICK, J. L. AYUSO-MATEOS, O. S. DALGARD, H. PAGE, V. LEHTINEN, P. CASEY, C. WILKINSON, J. L. VAZQUEZ-BARQUERO, et al. Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-up The British Journal of Psychiatry, October 1, 2003; 183(4): 323 - 331. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |